TME-SW
01698
XIAOMI-W
01810
TRIP.COM-S
09961
BIDU-SW
09888
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|
Cash flow from operating activities | |||||
Earning before tax | 15.85%-487.83M | 50.04%-1.1B | ---579.7M | 35.12%-2.21B | ---3.4B |
Profit adjustment | |||||
Interest (income) - adjustment | ---2.09M | ---- | ---- | ---- | ---- |
Impairment and provisions: | 1,109.45%46.34M | -100.63%-409K | ---4.59M | 13.64%64.42M | --56.69M |
-Impairmen of inventory (reversal) | 977.06%45.5M | -103.06%-1.97M | ---5.19M | 13.90%64.29M | --56.45M |
-Impairment of trade receivables (reversal) | 41.04%842K | 1,117.97%1.56M | --597K | -46.89%128K | --241K |
Asset sale loss (gain): | ---3.76M | -742.60%-9.11M | ---- | 530.22%1.42M | --225K |
-Loss (gain) on sale of property, machinery and equipment | ---3.76M | -742.60%-9.11M | ---- | 530.22%1.42M | --225K |
Depreciation and amortization: | -6.98%258.56M | 13.74%534.32M | --277.95M | 77.12%469.78M | --265.24M |
-Amortization of intangible assets | -0.12%39.97M | 3.75%79.58M | --40.02M | 6.37%76.7M | --72.11M |
Financial expense | -29.75%44.12M | -88.45%118.91M | --62.81M | -56.96%1.03B | --2.39B |
Special items | 237.01%87.23M | 3,918.56%80.77M | --25.88M | -89.69%2.01M | --19.51M |
Operating profit before the change of operating capital | 73.61%-57.43M | 40.85%-377.45M | ---217.64M | 4.12%-638.16M | ---665.55M |
Change of operating capital | |||||
Inventory (increase) decrease | -282.03%-69.38M | 91.01%-32.75M | --38.11M | -213.93%-364.37M | ---116.07M |
Accounts receivable (increase)decrease | 4.23%-45.96M | -390.40%-189.01M | ---47.99M | 49.06%65.09M | --43.67M |
Accounts payable increase (decrease) | 145.96%21.02M | -1,695.29%-80.56M | ---45.74M | -97.47%5.05M | --200M |
Special items for working capital changes | -111.18%-3.62M | 2,343.82%86.19M | --32.33M | 84.11%-3.84M | ---24.18M |
Cash from business operations | 35.52%-155.35M | 36.60%-593.6M | ---240.94M | -66.55%-936.23M | ---562.14M |
Other taxs | ---169K | 79.10%-14K | ---- | ---67K | ---- |
Net cash from operations | 35.45%-155.52M | 36.60%-593.61M | ---240.94M | -66.56%-936.3M | ---562.14M |
Cash flow from investment activities | |||||
Interest received - investment | --800K | ---- | ---- | ---- | ---- |
Sale of fixed assets | --11.71M | 2,739.55%25.13M | ---- | -86.02%885K | --6.33M |
Purchase of fixed assets | 64.58%-71.38M | 28.69%-331.31M | ---201.56M | 58.56%-464.62M | ---1.12B |
Recovery of cash from investments | -82.41%326.78M | -60.92%2.14B | --1.86B | --5.47B | ---- |
Cash on investment | 56.46%-576.47M | 70.72%-1.49B | ---1.32B | -410.04%-5.1B | ---1B |
Net cash from investment operations | -192.91%-308.57M | 460.57%338.2M | --332.11M | 95.57%-93.8M | ---2.11B |
Net cash before financing | -608.99%-464.09M | 75.20%-255.42M | --91.18M | 61.52%-1.03B | ---2.68B |
Cash flow from financing activities | |||||
New borrowing | -4.14%170.76M | -66.24%266.16M | --178.14M | 60.20%788.35M | --492.12M |
Refund | -30.85%-171.6M | 55.16%-298.11M | ---131.15M | -772.84%-664.86M | ---76.17M |
Interest paid - financing | 26.16%-38.71M | 21.14%-107.02M | ---52.43M | -2.95%-135.71M | ---131.82M |
Absorb investment income | --640.68M | --20M | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---2.08M | ---- | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | -86.46%480.1M | --3.55B |
Net cash from financing operations | 6,629.51%594.77M | -127.56%-126.8M | ---9.11M | -87.97%460.16M | --3.82B |
Effect of rate | 105.92%41K | -83.12%350K | ---692K | 465.61%2.07M | ---567K |
Net Cash | 59.24%130.69M | 32.94%-382.21M | --82.07M | -149.66%-569.93M | --1.15B |
Begining period cash | -53.72%328.98M | -44.41%710.84M | --710.84M | 872.40%1.28B | --131.5M |
Cash at the end | -41.97%459.7M | -53.72%328.98M | --792.22M | -44.41%710.84M | --1.28B |
Cash balance analysis | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.